|
|
Prepublished online as a Blood First Edition Paper on March 6, 2003; DOI 10.1182/blood-2002-09-2760.
Previous Article | Table of Contents | Next Article 
Blood, 1 July 2003, Vol. 102, No. 1, pp. 109-117
HEMATOPOIESIS
Differential STAT3, STAT5, and NF- B activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules
Julien Giron-Michel,
Anne Caignard,
Manuela Fogli,
Danièle Brouty-Boyé,
Diane Briard,
Marc van Dijk,
Raffaella Meazza,
Silvano Ferrini,
Caroline Lebousse-Kerdilès,
Denis Clay,
Heidi Bompais,
Salem Chouaib,
Bruno Péault, and
Bruno Azzarone
From U 506 Institut National Santé et Recherche Medicale (INSERM), U 542 INSERM, and U 268 INSERM, Hôpital Paul Brousse, Villejuif; U 487 INSERM, IGR, Villejuif, France; Istituto Gaslini, Genoa; Isitituto Nazionale per la Ricerca sul Cancro IST, Genoa, Italy; and Genmab, Utrecht, the Netherlands.
Different forms of interleukin-15 (IL-15) have been identified and shown to elicit different transduction pathways whose impact on hematopoiesis is poorly understood. We demonstrated herein that hematopoietic CD34+ cells constitutively produced endogenous secreted IL-15 (ES-IL-15) that activated different transcription factors and controlled the expression of several functional proteins, depending on the progenitor source. Thus, nuclear factor- B (NF- B) was activated in bone marrow (BM) and cord blood (CB) progenitors, whereas signal transducer and activator of transcription 3 (STAT3) and STAT5 activation was restricted to peripheral granulocytecolony-stimulating factor (G-CSF)mobilized and BM progenitors, respectively. ES-IL-15 acts through autocrine/paracrine loops controlled by high-affinity receptors involving IL-15 receptor (IL-15R ). Furthermore, ES-IL-15 was found to differentially control the expression of several functional molecules important for hematopoietic differentiation. Indeed, in BM precursors, neutralizing antiIL-15 monoclonal antibody (mAb) inhibits the expression of the c chain and of the chemokine stromal derived factor-1 (SDF-1) but had no effect on vascular cell adhesion molecule 1 (VCAM-1) and 1 integrin adhesion molecule expression. Conversely, in CB progenitors, antiIL-15 mAb inhibited VCAM-1 and 1 integrin expression without affecting c chain expression and, most important, up-regulated SDF-1 expression. In conclusion, unprimed human hematopoietic CD34+ cells secrete cell-unbound IL-15, which activates through autocrine/paracrine loop distinct signaling pathways, depending on the progenitor source, thereby influencing the expression of several molecules important in the control of hematopoiesis. (Blood. 2003;102:109-117)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Berger, M. Berger, R. C. Hackman, M. Gough, C. Elliott, M. C. Jensen, and S. R. Riddell
Safety and immunologic effects of IL-15 administration in nonhuman primates
Blood,
September 17, 2009;
114(12):
2417 - 2426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fontalba, O. Gutierrez, and J. L. Fernandez-Luna
NLRP2, an Inhibitor of the NF-{kappa}B Pathway, Is Transcriptionally Activated by NF-{kappa}B and Exhibits a Nonfunctional Allelic Variant
J. Immunol.,
December 15, 2007;
179(12):
8519 - 8524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Masri, W. Xu, S. A. A. Comhair, K. Asosingh, M. Koo, A. Vasanji, J. Drazba, B. Anand-Apte, and S. C. Erzurum
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol,
September 1, 2007;
293(3):
L548 - L554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Wang, J. W. Holland, A. Carrington, J. Zou, and C. J. Secombes
Molecular and Functional Characterization of IL-15 in Rainbow Trout Oncorhynchus mykiss: A Potent Inducer of IFN-{gamma} Expression in Spleen Leukocytes
J. Immunol.,
August 1, 2007;
179(3):
1475 - 1488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chiossone, C. Vitale, F. Cottalasso, S. Moretti, B. Azzarone, L. Moretta, and M. C. Mingari
Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells
Blood,
May 1, 2007;
109(9):
3767 - 3775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pelletier and D. Girard
Differential Effects of IL-15 and IL-21 in Myeloid (CD11b+) and Lymphoid (CD11b-) Bone Marrow Cells
J. Immunol.,
July 1, 2006;
177(1):
100 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ozawa, H. Tada, Y. Sugawara, A. Uehara, T. Sasano, H. Shimauchi, H. Takada, and S. Sugawara
Endogenous IL-15 Sustains Recruitment of IL-2R{beta} and Common {gamma} and IL-2-Mediated Chemokine Production in Normal and Inflamed Human Gingival Fibroblasts
J. Immunol.,
October 15, 2004;
173(8):
5180 - 5188.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|